ARTICLE | Company News
Profile in cystic fibrosis deal
March 1, 2001 8:00 AM UTC
Inhaled drug delivery company Profile Therapeutics (LSE:PTP) and Forum Bioscience (Redhill, U.K.) will develop and market an inhaled generic antibiotic to prevent lung infections in cystic fibrosis pa...